John Valliant
Founder at FUSN PHAR
Net worth: 7 M $ as of 30/04/2024
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Damian Lamb | M | 52 |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin. | - |
Pablo Cagnoni | M | 60 | 5 years | |
Steven Gannon | M | 62 | 4 years | |
Sheila Singh | M | - |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin. | 3 years |
Donald Bergstrom | M | 52 | 3 years | |
Bettina Hamelin | M | - |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin. | 3 years |
Philina Lee | M | 47 | 3 years | |
Peter Pattison | M | - |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin. | 3 years |
Amanda Cray | F | - | - | |
Karen Gulenchyn | F | - |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin. | - |
Eric Burak | M | - |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin. | 12 years |
Annick Van den Abbeele | M | - |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin. | - |
Jean-Claude Provost | M | 60 |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin. | - |
Bruno Paquin | M | - |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin. | - |
Gay Yuyitung | M | - |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin. | - |
Christopher Kelly | M | - |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin. | - |
Lana Janes | M | - |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin. | 3 years |
Barbara Duncan | F | 59 | 4 years | |
Dean Mountain | M | - |
McMaster University
| - |
Marc Letendre | M | - |
McMaster University
| - |
Michael Verbora | M | - |
McMaster University
| 6 years |
Martin Kolb | M | - |
McMaster University
| - |
Arjun Kumar | M | - |
McMaster University
| - |
Jeanne Tan | F | - |
McMaster University
| - |
Chris Sinding | M | - |
McMaster University
| - |
Arlene Dosen | F | - |
McMaster University
| - |
Jerry Hurley | M | - |
McMaster University
| - |
Pamela Swett | F | - |
McMaster University
| - |
David Huctwith | M | - |
McMaster University
| - |
Karen Mossaman | F | - |
McMaster University
| - |
Fiona McNeill | F | - |
McMaster University
| - |
Sandeep Raha | M | - |
McMaster University
| - |
Judith Shedden | F | - |
McMaster University
| - |
Sara Bannerman | F | - |
McMaster University
| - |
Spencer Pope | M | - |
McMaster University
| - |
Judy West-Mays | F | - |
McMaster University
| - |
Constantinos Economou | M | - |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin. | - |
Anton Knezovic | M | - |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin. | - |
Barry Nicol | M | - |
McMaster University
| - |
Juliet Daniel | F | - |
McMaster University
| - |
Sonny Kohli | M | - |
McMaster University
| 14 years |
Khaled Hassanein | M | - |
McMaster University
| - |
Stephanie Baschiera | F | - |
McMaster University
| - |
Christina Bryce | F | - |
McMaster University
| - |
Michael Ferencich | M | - |
McMaster University
| - |
Jeffrey Weitz | M | - |
McMaster University
| - |
James Macpherson | M | - |
McMaster University
| - |
James B. Mahony | M | - |
McMaster University
| - |
Mary Maher | F | 63 |
McMaster University
| - |
Ronald Campbell Loucks | M | - |
McMaster University
| - |
John Bienenstock | M | 87 |
McMaster University
| - |
Robert G. Cooper | M | - |
McMaster University
| - |
James Paul | M | - |
McMaster University
| - |
Emõke J. E. Szathmáry | M | 81 |
McMaster University
| - |
Paul D. Campbell | M | 76 |
McMaster University
| - |
Peter Horsewood | M | - |
McMaster University
| - |
Richard Rossman | M | - |
McMaster University
| - |
Kevin P. D. Smith | M | 61 |
McMaster University
| - |
Rocco Taglioni | M | - |
McMaster University
| - |
Jim A. Wright | M | - |
McMaster University
| 14 years |
H. Barber | M | - |
McMaster University
| - |
Fraser Reeve Berrill | M | 75 |
McMaster University
| - |
Lynton R. Wilson | M | 84 |
McMaster University
| - |
John Thornback | M | - |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin. | - |
Grant B. Walsh | M | 75 |
McMaster University
| - |
Natalia K. Nikolova | M | - |
McMaster University
| 25 years |
John C. Luxat | M | - |
McMaster University
| - |
Joseph Gabriele | M | - |
McMaster University
| - |
Marion B. Lyver | M | - |
McMaster University
| - |
John Manley | M | 74 |
McMaster University
| - |
Michael T. Newhouse | M | - |
McMaster University
| - |
John Crowley | M | 51 | 5 years | |
John Wallace | M | 67 |
McMaster University
| - |
Woo-Young Kim | M | - |
McMaster University
| 13 years |
Mark Larché | M | - |
McMaster University
| - |
Connie A. Stefankiewicz | F | - |
McMaster University
| - |
Gary Kain | M | - |
McMaster University
| - |
Marc Kealey | M | - |
McMaster University
| - |
Paul Dixon Allison | M | - |
McMaster University
| - |
Yaser M. Haddara | M | - |
McMaster University
| - |
Emechete Onuoha | M | - |
McMaster University
| - |
Roger Couldrey | M | - |
McMaster University
| - |
S. R. Rafael Jose Faucher | M | - |
McMaster University
| - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Cindy Ward | F | - |
McMaster University
| 21 years |
Mark Mihaljevic | M | - |
McMaster University
| 3 years |
Lisa Walter | M | - |
McMaster University
| 10 years |
Xianming Zhu | M | 41 |
McMaster University
| 2 years |
Aidan Giangregorio | M | - |
McMaster University
| 6 years |
Ryan Mitchell | M | - |
McMaster University
| 10 years |
Lynn Wick | F | - | 4 years | |
Joel Wagner | M | - |
McMaster University
| 6 years |
Chau Khuong | M | 48 | 4 years | |
Paul Easterbrook | M | - |
McMaster University
| 6 years |
T. Buckley | M | 48 |
McMaster University
| 6 years |
Rami Rahal | M | - |
McMaster University
| 4 years |
Ryan T. Goulding | M | - |
McMaster University
| 7 years |
Todd D'Amico | M | - |
McMaster University
| 6 years |
Kris Somers | M | - |
McMaster University
| 5 years |
Colum Bastable | M | 77 |
McMaster University
| - |
Jeff Pootoolal | M | - |
McMaster University
| 7 years |
Statistics
Country | Connections | % of total |
---|---|---|
Canada | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- John Valliant
- Personal Network